cefuroxime has been researched along with Bronchitis in 42 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized, double-blind, double-dummy, three-arm parallel design, multicentre study was conducted among adult patients with acute exacerbation of chronic bronchitis (AECB) in order to compare the efficacy and safety of two different doses of levofloxacin with cefuroxime axetil." | 9.09 | Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. ( Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R, 1999) |
| "The objective of this randomized, double-blind study was to compare the clinical efficacy of levofloxacin at two different dosages with that of cefuroxime axetil in patients with acute purulent exacerbations of chronic bronchitis and, in particular, to assess the impact of the susceptibility to levofloxacin on the clinical findings." | 9.09 | Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. ( Davies, BI; Maesen, FP, 1999) |
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 9.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| " (4 x 300 mg, day 1-14), cefuroxime (CAS 55268-75-2) (2 x 250 mg daily for day 1-6), ambroxol (CAS 18683-91-5) (3 x 30 mg for day 1-3, 2 x 30 mg for days 4-14) and matched placebo in acute bronchitis." | 9.09 | Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. ( Carls, C; de Mey, C; Geib, A; Matthys, H; Ryś, A; Wittig, T, 2000) |
| "Five hundred thirty-seven patients were enrolled in two independent, investigator-blinded, multicenter, randomized clinical trials comparing the clinical and bacteriologic efficacies and the safety of 5- or 10-day treatment with cefuroxime axetil with those of 10-day treatment with amoxicillin-clavulanate in the treatment of secondary bacterial infections of acute bronchitis." | 9.08 | Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis. ( Collins, JJ; Drehobl, M; Giguere, G; Henry, D; Puopolo, A; Rhudy, J; Ruoff, GE; Schoenberger, J, 1995) |
| "A prospective, multicentre, randomized, open-label, parallel group study compared the efficacy, safety and tolerability of cefuroxime 750 mg iv administered either twice daily (bd) or three times daily (tds) for 48-72 h, followed by oral cefuroxime axetil 500 mg bd for 5-7 days in a sequential therapy regimen for the treatment of acute exacerbations of chronic bronchitis." | 9.08 | Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis. ( Droszcz, W; Marr, C; Reisenberg, K; Staley, H; Vogel, F; Vondra, V, 1997) |
| "In a prospective, multicenter, double-blind study, the interval to clinical relapse in patients with acute bacterial exacerbations of chronic bronchitis from whom a pretherapy pathogen was isolated was compared following treatment with ciprofloxacin or cefuroxime axetil." | 9.08 | Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. ( Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R, 1998) |
| "128 Patients (45 female, 83 male) with acute exacerbations of chronic bronchitis were treated with either cefuroxime axetil 2 x 500 mg/d (n = 65) or ofloxacin 2 x 200 mg/d for 7-8 days in a randomized controlled multicenter trial." | 9.07 | [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin]. ( Kleckow, M, 1991) |
| "The aim of this multicenter, prospective randomized trial was to compare the efficacy and safety of cefuroxime-axetil and amoxycillin/clavulanic acid for the treatment of infectious bronchitis in the elderly patient." | 9.06 | [Ambulatory treatment with cefuroxime-axetil of infectious bronchitis in patients sixty years of age or older: comparative study of the combination of amoxicillin and clavulanic acid]. ( Chiche, D; Hugonot, L; Hugonot, R; Pappo, M, 1990) |
| "Cefuroxime axetil was compared with cefaclor for the therapy for lower respiratory tract infections." | 9.06 | Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections. ( Anthony, WC; Craig, W; File, TM; Lifland, P; Schleupner, CJ; Tan, J; Vogelman, B, 1988) |
| "followed by 625 mg orally t." | 6.67 | Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections. ( Brambilla, C; Cunningham, K; Kastanakis, S; Knight, S, 1992) |
| "A regimen of cefprozil (500 mg twice daily), a new oral cephalosporin with a broad in vitro spectrum of antimicrobial activity, was compared to standard regimens of cefaclor (500 mg three times daily), cefuroxime axetil (500 mg twice daily), or amoxicillin/clavulanate (500 mg/125 mg three times daily) for the treatment of lower respiratory tract infections (mainly bronchitis and acute exacerbations of chronic bronchitis) in adults in three open-label, randomized trials." | 6.17 | Review of the experience with cefprozil for the treatment of lower respiratory tract infections. ( Pelletier, LL, 1992) |
| "Free cefuroxime has been obtained by equilibrium dialysis and measured by HPLC." | 5.28 | [Binding of cefuroxime to macromolecules from bronchitic sputum in patients with chronic bronchitis]. ( Chiche, D; Houdret, N; Lhermitte, M; Roussel, P, 1991) |
| "A randomized, double-blind, double-dummy, three-arm parallel design, multicentre study was conducted among adult patients with acute exacerbation of chronic bronchitis (AECB) in order to compare the efficacy and safety of two different doses of levofloxacin with cefuroxime axetil." | 5.09 | Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. ( Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R, 1999) |
| "The objective of this randomized, double-blind study was to compare the clinical efficacy of levofloxacin at two different dosages with that of cefuroxime axetil in patients with acute purulent exacerbations of chronic bronchitis and, in particular, to assess the impact of the susceptibility to levofloxacin on the clinical findings." | 5.09 | Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity. ( Davies, BI; Maesen, FP, 1999) |
| "The bacteriological eradication rates of Streptococcus pneumoniae from sputum of patients experiencing acute exacerbations of chronic bronchitis (WHO definition) have been compared following therapy with either cefuroxime axetil 250 mg b." | 5.09 | Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime. ( Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P, 1999) |
| " (4 x 300 mg, day 1-14), cefuroxime (CAS 55268-75-2) (2 x 250 mg daily for day 1-6), ambroxol (CAS 18683-91-5) (3 x 30 mg for day 1-3, 2 x 30 mg for days 4-14) and matched placebo in acute bronchitis." | 5.09 | Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. ( Carls, C; de Mey, C; Geib, A; Matthys, H; Ryś, A; Wittig, T, 2000) |
| "Five hundred thirty-seven patients were enrolled in two independent, investigator-blinded, multicenter, randomized clinical trials comparing the clinical and bacteriologic efficacies and the safety of 5- or 10-day treatment with cefuroxime axetil with those of 10-day treatment with amoxicillin-clavulanate in the treatment of secondary bacterial infections of acute bronchitis." | 5.08 | Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis. ( Collins, JJ; Drehobl, M; Giguere, G; Henry, D; Puopolo, A; Rhudy, J; Ruoff, GE; Schoenberger, J, 1995) |
| " We have investigated the impact on normal human intestinal flora in a 10-day course with cefetamet-pivoxil (CET, 500 mg BID) in comparison to cefixime (CFX, 400 mg qD) or cefuroxime axetil (CA, 250 mg BID) in 24 patients suffering from acute exacerbation of chronic bronchitis." | 5.08 | Betalactam therapy and intestinal flora. ( Cassetta, MI; Conti, S; Dei, R; Fallani, S; Mazzei, T; Novelli, A, 1995) |
| "A prospective, multicentre, randomized, open-label, parallel group study compared the efficacy, safety and tolerability of cefuroxime 750 mg iv administered either twice daily (bd) or three times daily (tds) for 48-72 h, followed by oral cefuroxime axetil 500 mg bd for 5-7 days in a sequential therapy regimen for the treatment of acute exacerbations of chronic bronchitis." | 5.08 | Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis. ( Droszcz, W; Marr, C; Reisenberg, K; Staley, H; Vogel, F; Vondra, V, 1997) |
| "In a prospective, multicenter, double-blind study, the interval to clinical relapse in patients with acute bacterial exacerbations of chronic bronchitis from whom a pretherapy pathogen was isolated was compared following treatment with ciprofloxacin or cefuroxime axetil." | 5.08 | Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. ( Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R, 1998) |
| "128 Patients (45 female, 83 male) with acute exacerbations of chronic bronchitis were treated with either cefuroxime axetil 2 x 500 mg/d (n = 65) or ofloxacin 2 x 200 mg/d for 7-8 days in a randomized controlled multicenter trial." | 5.07 | [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin]. ( Kleckow, M, 1991) |
| "The aim of this multicenter, prospective randomized trial was to compare the efficacy and safety of cefuroxime-axetil and amoxycillin/clavulanic acid for the treatment of infectious bronchitis in the elderly patient." | 5.06 | [Ambulatory treatment with cefuroxime-axetil of infectious bronchitis in patients sixty years of age or older: comparative study of the combination of amoxicillin and clavulanic acid]. ( Chiche, D; Hugonot, L; Hugonot, R; Pappo, M, 1990) |
| "Cefuroxime axetil was compared with cefaclor for the therapy for lower respiratory tract infections." | 5.06 | Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections. ( Anthony, WC; Craig, W; File, TM; Lifland, P; Schleupner, CJ; Tan, J; Vogelman, B, 1988) |
| " Metaanalyses of clinical trials demonstrate that uncomplicated acute otitis media in children can be successfully treated with a 5-day course of cefuroxime axetil." | 4.80 | Short-course antibiotic therapy for infections with a single causative pathogen. ( Adam, D, 2000) |
| " The sensitivity of clinically significant 96 strains from patients with pyelonephritis and 180 strains from patients with lower respiratory tract infections (pneumonia, COPD) was compared for cefuroxime and cefotaxime or ceftriaxone according NCCLS recommendations during 2000-2001 years." | 3.72 | [Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital]. ( Bogdanov, MB; Chernen'kaia, TV, 2003) |
| "followed by 625 mg orally t." | 2.67 | Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections. ( Brambilla, C; Cunningham, K; Kastanakis, S; Knight, S, 1992) |
| "Cefuroxime has shown good clinical efficacy and tolerance in lower respiratory tract infections." | 2.38 | [Parenteral cephalosporins for the treatment of lower respiratory tract infections]. ( Vogel, F, 1993) |
| "Free cefuroxime has been obtained by equilibrium dialysis and measured by HPLC." | 1.28 | [Binding of cefuroxime to macromolecules from bronchitic sputum in patients with chronic bronchitis]. ( Chiche, D; Houdret, N; Lhermitte, M; Roussel, P, 1991) |
| "Cefuroxime is a very effective agent for the treatment of severe purulent respiratory infections." | 1.26 | Experience with cefuroxime in 190 patients with severe respiratory infections. ( Kennedy, MR; Mullinger, BM; Pines, A; Raafat, H, 1980) |
| "1." | 1.26 | [Study of cefuroxime in pediatric field (author's transl)]. ( Inaguma, K; Iwai, N; Miyazu, M; Osuga, T; Sasaki, A, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (30.95) | 18.7374 |
| 1990's | 20 (47.62) | 18.2507 |
| 2000's | 9 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogdanov, MB | 2 |
| Chernen'kaia, TV | 2 |
| Guillemin, P | 1 |
| Gerster, JC | 1 |
| Spencer, RC | 1 |
| Nolen, TM | 1 |
| Hutchison, J | 1 |
| Phillips, HL | 1 |
| Stott, P | 1 |
| Porowski, T | 1 |
| Zoch-Zwierz, W | 1 |
| Porowska, H | 1 |
| Jadeszko, I | 1 |
| Molotkov, VN | 2 |
| Chernushenko, EF | 1 |
| Maliuk, VM | 1 |
| Zhukovskiĭ, LI | 1 |
| Bil'ko, IP | 1 |
| Castello, D | 1 |
| Sacchetti, L | 1 |
| Brero, P | 1 |
| Poncini, L | 1 |
| Pines, A | 2 |
| Raafat, H | 2 |
| Kennedy, MR | 1 |
| Mullinger, BM | 1 |
| Havard, CW | 1 |
| Bax, RP | 1 |
| Samanta, TC | 1 |
| Pearson, RM | 1 |
| Brumfitt, W | 1 |
| Hamilton-Miller, JM | 1 |
| Dash, CH | 1 |
| Ball, P | 1 |
| Droszcz, P | 1 |
| Doboszyńska, A | 1 |
| Zielonka, TM | 1 |
| Vogel, F | 2 |
| Schwigon, CD | 1 |
| Cuhorst, R | 1 |
| Gabor, M | 1 |
| Zinndorf, J | 1 |
| Springsklee, M | 1 |
| Henry, D | 1 |
| Ruoff, GE | 1 |
| Rhudy, J | 1 |
| Puopolo, A | 1 |
| Drehobl, M | 2 |
| Schoenberger, J | 1 |
| Giguere, G | 1 |
| Collins, JJ | 1 |
| Novelli, A | 1 |
| Mazzei, T | 1 |
| Fallani, S | 1 |
| Dei, R | 1 |
| Cassetta, MI | 1 |
| Conti, S | 1 |
| Bart, BIa | 1 |
| Solov'ev, SS | 1 |
| Zaseeva, OV | 1 |
| Benevskaia, VF | 1 |
| Mikhaĭlusova, MP | 1 |
| Romanova, MV | 1 |
| Kasatikova, LA | 1 |
| Droszcz, W | 1 |
| Vondra, V | 1 |
| Reisenberg, K | 1 |
| Marr, C | 1 |
| Staley, H | 1 |
| Chodosh, S | 1 |
| McCarty, J | 1 |
| Farkas, S | 1 |
| Tosiello, R | 1 |
| Shan, M | 1 |
| Aneiro, L | 1 |
| Kowalsky, S | 1 |
| Shah, PM | 1 |
| Maesen, FP | 2 |
| Dolmann, A | 1 |
| Vetter, N | 1 |
| Fiss, E | 1 |
| Wesch, R | 1 |
| Davies, BI | 1 |
| Anzueto, A | 1 |
| Rizzo, JA | 1 |
| Grossman, RF | 1 |
| Zuck, P | 1 |
| Petitpretz, P | 1 |
| Geslin, P | 1 |
| Rio, Y | 1 |
| Leblanc, F | 1 |
| Van Herwaarden, CL | 1 |
| Langan, CE | 1 |
| Siemon, G | 1 |
| Rudolph, C | 1 |
| Keyserling, CH | 1 |
| Nemeth, MA | 1 |
| Tack, KJ | 1 |
| Matthys, H | 1 |
| de Mey, C | 1 |
| Carls, C | 1 |
| Ryś, A | 1 |
| Geib, A | 1 |
| Wittig, T | 1 |
| Adam, D | 1 |
| Rao, PP | 1 |
| Mopkar, O | 1 |
| Desai, A | 1 |
| Gao, B | 1 |
| Hu, J | 1 |
| Deng, W | 1 |
| Woolhouse, IS | 1 |
| Hill, SL | 1 |
| Stockley, RA | 1 |
| Hirama, Y | 1 |
| Iwasaki, A | 1 |
| Suzuki, H | 1 |
| Nakazawa, S | 2 |
| Narita, A | 1 |
| Niino, K | 1 |
| Satoh, H | 1 |
| Chikaoka, H | 1 |
| Oka, S | 1 |
| Hotta, M | 1 |
| Oikawa, T | 1 |
| Sunagawa, K | 1 |
| Nanri, S | 1 |
| Yamashita, N | 1 |
| Akita, H | 1 |
| Ichihashi, Y | 1 |
| Iwai, N | 1 |
| Sasaki, A | 1 |
| Miyazu, M | 1 |
| Osuga, T | 1 |
| Inaguma, K | 1 |
| Brambilla, C | 1 |
| Kastanakis, S | 1 |
| Knight, S | 1 |
| Cunningham, K | 1 |
| Landau, Z | 1 |
| Schlaffer, F | 1 |
| Pitlik, S | 1 |
| Pelletier, LL | 1 |
| Lhermitte, M | 1 |
| Chiche, D | 2 |
| Houdret, N | 1 |
| Roussel, P | 1 |
| Kleckow, M | 1 |
| Hugonot, R | 1 |
| Hugonot, L | 1 |
| Pappo, M | 1 |
| Schleupner, CJ | 1 |
| Anthony, WC | 1 |
| Tan, J | 1 |
| File, TM | 1 |
| Lifland, P | 1 |
| Craig, W | 1 |
| Vogelman, B | 1 |
| Feshchenko, IuI | 1 |
4 reviews available for cefuroxime and Bronchitis
| Article | Year |
|---|---|
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents | 1994 |
[Parenteral cephalosporins for the treatment of lower respiratory tract infections].
Topics: Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Cross Infection; Humans; Infusions, Intrave | 1993 |
Short-course antibiotic therapy for infections with a single causative pathogen.
Topics: Anti-Bacterial Agents; Bronchitis; Cefuroxime; Cephalosporins; Drug Administration Schedule; Humans; | 2000 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumo | 1992 |
24 trials available for cefuroxime and Bronchitis
| Article | Year |
|---|---|
[Place of ketocef in treating chronic bronchitis and its effect on the patient's body].
Topics: Adult; B-Lymphocytes; Bronchitis; Cefuroxime; Cephalosporins; Chloramphenicol; Chronic Disease; Clin | 1983 |
[Results of a clinical trial of the use of a methoxyamine (cefuroxime) in respiratory tract infections in children].
Topics: Bacterial Infections; Bronchitis; Bronchopneumonia; Cefuroxime; Cephalosporins; Child; Child, Presch | 1981 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents | 1994 |
[Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study].
Topics: Ampicillin; Bacterial Infections; Bronchitis; Cefuroxime; Drug Therapy, Combination; Female; Humans; | 1993 |
Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavul | 1995 |
Betalactam therapy and intestinal flora.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Anaerobic; Br | 1995 |
[The use of the cephalosporin antibiotic Zinnat under polyclinic conditions in treating patients with bronchopulmonary infections].
Topics: Acute Disease; Adolescent; Adult; Ambulatory Care; Bronchitis; Cefuroxime; Cephalosporins; Chronic D | 1996 |
Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bronchitis; Cardiovascular Diseases; Cefuroxim | 1997 |
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chr | 1998 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chron | 1999 |
Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.
Topics: Aged; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind M | 1999 |
Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Cefixime; Cefuroxime; Cephalosporins; Chronic Disease; D | 1999 |
International study comparing cefdinir and cefuroxime axetil in the treatment of patients with acute exacerbation of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; B | 2000 |
Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
Topics: Acute Disease; Adolescent; Adult; Aged; Ambroxol; Bronchitis; Bronchodilator Agents; Cefuroxime; Cep | 2000 |
Comparative trial to evaluate the efficacy and tolerability of cefuroxime 250mg with probenecid 250mg with cefuroxime 500mg in the management of community acquired pneumonia, acute bronchitis and acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adult; Bronchitis; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Th | 2000 |
[Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Topics: Adolescent; Adult; Aged; Bronchitis; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Female; Gr | 1998 |
Symptom resolution assessed using a patient directed diary card during treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Analysis of Variance; Androstadienes; Anti-Inflammato | 2001 |
Cefuroxime in severe respiratory infections: a double-blind comparison of two doses.
Topics: Bronchiectasis; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Clinical Trials as Topic; D | 1979 |
Cefuroxime and cefuroxime axetil versus amoxicillin plus clavulanic acid in the treatment of lower respiratory tract infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium | 1992 |
Cefuroxime axetil vs. augmentin for the treatment of acute bronchitis and exacerbation of chronic obstructive pulmonary disease.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Cefuroxime; Chi-Square Distr | 1992 |
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumo | 1992 |
[Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Cefuroxime; Chronic Di | 1991 |
[Ambulatory treatment with cefuroxime-axetil of infectious bronchitis in patients sixty years of age or older: comparative study of the combination of amoxicillin and clavulanic acid].
Topics: Acute Disease; Aged; Ambulatory Care; Amoxicillin; Bronchitis; Cefuroxime; Cephalosporins; Clavulani | 1990 |
Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Bronchitis; Cefaclor; Cefuro | 1988 |
16 other studies available for cefuroxime and Bronchitis
| Article | Year |
|---|---|
[Microbiological evaluation of differences between cephalosporins of second and third generations in general hospital].
Topics: Anti-Bacterial Agents; Bronchitis; Cefotaxime; Ceftriaxone; Cefuroxime; Gram-Negative Bacteria; Hosp | 2003 |
[Reactive arthritis induced by Clostridium difficile enteritis].
Topics: Ankle Joint; Arthritis, Reactive; Bronchitis; Cefuroxime; Clostridioides difficile; Diagnosis, Diffe | 2005 |
A comparison of cefuroxime axetil and amoxycillin in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bronchitis; Cefuroxi | 1989 |
A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.
Topics: Alabama; Anti-Bacterial Agents; Bronchitis; Cefaclor; Cefuroxime; Clinical Trials as Topic; Communit | 1989 |
Cefuroxime axetil in the treatment of acute bronchitis in UK general practice.
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Bronchitis; Cefuroxime; Clinical Trials as | 1989 |
[The concentration of plasma anion oxalate in children treatment antibiotics beta lactame].
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anions; Anti-Bacterial Agents; beta-Lacta | 2006 |
Experience with cefuroxime in 190 patients with severe respiratory infections.
Topics: Adolescent; Adult; Aged; Bronchitis; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; | 1980 |
Sputum and blood concentrations of cefuroxime in lower respiratory tract infection.
Topics: Bronchitis; Bronchopneumonia; Cefuroxime; Cephalosporins; Humans; Kinetics; Saliva; Sputum | 1980 |
[Sultamicillin and cefuroxime axetil in the ambulatory treatment of exacerbated chronic bronchitis].
Topics: Adult; Ampicillin; Bronchitis; Cefuroxime; Chronic Disease; Drug Therapy, Combination; Female; Human | 1993 |
The infection-free interval: its use in evaluating antimicrobial treatment of acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Bacterial Infections; Bronchitis; Cefuroxime; Ciprofloxacin; Clarithromycin; Humans; | 1999 |
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis; Cefuroxime; Cepha | 2000 |
[Fundamental and clinical studies of cefuroxime, a new cephalosporin antibiotic, in pediatric field (author's transl)].
Topics: Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Resistan | 1979 |
[Experience with cefuroxime in pediatric field (author's transl)].
Topics: Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Resistan | 1979 |
[Study of cefuroxime in pediatric field (author's transl)].
Topics: Bacteria; Bacterial Infections; Bronchitis; Cefuroxime; Cephalosporins; Child; Child, Preschool; Dru | 1979 |
[Binding of cefuroxime to macromolecules from bronchitic sputum in patients with chronic bronchitis].
Topics: Bronchitis; Cefuroxime; Chromatography, High Pressure Liquid; Chronic Disease; Humans; In Vitro Tech | 1991 |
[Endolymphatic therapy in the combined treatment of patients with respiratory diseases].
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bronchitis; Cefotaxime; Cefuroxime; Eval | 1985 |